CASP3 and lip and oral cavity carcinoma: Oral cancer cells exhibited higher activated caspase 3 (+) (%) from X-ray/SK2 treatment than normal cells, i.e., 82.1%, 88.1% vs. 19.6% for Ca9-22, CAL 27 vs. S-G (Figure 3B).